First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation Treatment (The RAAFT Study)

NCT00392054 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
127
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Population Health Research Institute

Collaborators